 
PH.2442_Risk Evaluation Mitigation Strategy (REMS) 
1 
 
 
 
RESPONSIBLE DEPARTMENT: 
Retail Pharmacy/Community Pharmacy 
SUBJECT:  
Risk Evaluation Mitigation Strategy (REMS) 
PAGES: 
2 
REPLACES POLICY (NUMBER/DATE): 
PH.2442 (01/27/2022) 
ORIGINAL EFFECTIVE 
DATE: 02/07/2017 
REVISIONS EFFECTIVE: 
03/29/2023 
POLICY NUMBER:  
PH.2442 
 
SCOPE: 
Applies to team members who work in or for Our Lady of the Lake Hospital, Inc. (OLOLH) pharmacies. 
PURPOSE: 
This policy assures that REMS processes are followed. 
POLICY: 
This policy specifies how the pharmacy, its employees, and its patients will participate in the provision of drug therapies 
that have established REMS programs. [URAC P-OPS 5-3 (a)] 
 
DEFINITIONS: 
REMS (Risk Evaluation Mitigation Strategy) is a strategy to manage a known or potential serious risk associated with 
a drug or biological product. A REMS will be required if the Food and Drug Administration (FDA) determines that a 
REMS is necessary to ensure the benefits of the drug or biological product outweigh its risks. A REMS can include a 
Medication Guide, Patient Package Insert, a communication plan, elements to assure safe use, and an implementation 
system.  
PROCEDURE: [URAC P-OPS 5-3 (a, b)] [URAC PM 5-1 (b)] 
A. It is not uncommon for some drug products to have FDA-approved REMS programs. So me of these 
programs place specific requirements on prescribers and patients. S ome add responsibilities for 
pharmacy providers.  
1. The pharmacy staff will comply with the manufacturer’s FDA-approved REMS program 
requirements. 
2. The pharmacy will notify patients and/or prescribers of any new FDA guidance or self-imposed 
manufacturer restriction that could cause a potential safety event. 
3. Each patient will receive a patient monograph for each newly prescribed drug therapy. 
4. Each patient will require other printed materials as required by the specific REMS program 
requirements. These may include Medication Guides or similar printed items. 
5. Patients will be entered in any required REMS program registry. 
6. A list of REMS medications and their requirements can be found at 
http://www.accessdata.fda.gov/scripts/cder/rems/index.cfm  
7. The drug(s) identified above with registry requirements are flagged in the pharmacy operating 
system as to special requirements upon dispensing (registry verification, etc.) to prompt 
employees to comply with REMS requirements.  
 
 
OUR LADY OF THE LAKE HOSPITAL 
 
 
3/29/2023 1:32 PM 
 
 
PH.2442_Risk Evaluation Mitigation Strategy (REMS) 
2 
8. Drugs with REMS requirements are flagged in the pharmacy operating system under drug type 
“REMS”.  
9. A list of REMS drugs, as well as the requirements, is posted in the pharmacy online shared 
folder under REMS. 
 
Note:  The information described herein does not create any legal rights and FMOLHS reserves the right to deviate 
from, revise or eliminate this policy, at any time, in its sole discretion. 
 
STATUTORY/REGULATORY AUTHORITY: 
• URAC Standards: P-OPS 5-3, PM 5-1 
• ACHC Standards: DRX5-5A, DRX7-18A 
 
ATTACHMENTS:  
N/A 
 
Policy Oversight by: 
 
Senior Director of Pharmacy for Our Lady of the Lake Hospital, Inc.  
 